theory clinical_14_2
imports Main

begin

typedecl entity
typedecl event

consts
  BRCA2 :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Human :: "entity ⇒ bool"
  Repair :: "event ⇒ bool"
  Homologous :: "entity ⇒ bool"
  Recombination :: "event ⇒ bool"
  Involved :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Binding :: "event ⇒ bool"
  Joining :: "event ⇒ bool"
  Catalyze :: "event ⇒ event ⇒ bool"
  Promote :: "event ⇒ bool"
  Patient :: "event ⇒ event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair in humans. *)
axiomatization where
  explanation_1: "∃x y z e. BRCA2 x ∧ RAD51 y ∧ Human z ∧ Repair e ∧ Homologous x ∧ Homologous y ∧ Recombination e ∧ Involved e ∧ Agent e x ∧ Agent e y ∧ In e z"

(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Undamaged z ∧ Homologous z ∧ Binding e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Joining e2 ∧ Agent e2 z ∧ Catalyze e1 e2"

theorem hypothesis:
  assumes asm: "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Human z ∧ Undamaged y ∧ Homologous y"
  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  shows "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Human z ∧ Undamaged y ∧ Homologous y ∧ Joining e1 ∧ Agent e1 y ∧ Promote e2 ∧ Agent e2 x ∧ Patient e2 e1 ∧ Via e1 z ∧ In e1 z"
proof -
  (* From the premise, we have known information about BRCA2, Molecules, RAD51, Human, Undamaged, and Homologous. *)
  from asm have "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Human z ∧ Undamaged y ∧ Homologous y" by force
  (* Explanation 2 states that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)
  (* We have the logical relation Implies(C, D), which implies that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)
  (* From explanation_2, we can infer the existence of a joining event e1 and a catalyzing event e2. *)
  then have "Joining e1 ∧ Agent e1 y ∧ Catalyze e2 e1 ∧ Agent e2 x ∧ Agent e2 z" sledgehammer
  (* Since the catalyzing event e2 involves BRCA2 and RAD51, we can infer that BRCA2 promotes the joining via RAD51. *)
  then have "Promote e2 ∧ Patient e2 e1 ∧ Via e1 z ∧ In e1 z" <ATP>
  (* Therefore, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
